Serge Belanger
Stock Analyst at Needham
(4.75)
# 640
Out of 4,596 analysts
952
Total ratings
50.1%
Success rate
14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Maintained: Buy | $18 | $8.38 | +114.93% | 15 | Aug 3, 2026 | |
| OCS Oculis Holding AG | Maintained: Buy | $38 | $11.90 | +219.33% | 9 | Aug 3, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $102 | $76.42 | +33.47% | 51 | Jul 30, 2026 | |
| OMER Omeros | Maintained: Hold | n/a | $12.54 | - | 54 | Jul 27, 2026 | |
| PCRX Pacira BioSciences | Maintained: Buy | $32 | $26.88 | +19.05% | 80 | Jul 27, 2026 | |
| NAMS NewAmsterdam Pharma Company | Maintained: Buy | $48 | $27.38 | +75.31% | 17 | Jul 24, 2026 | |
| TRVI Trevi Therapeutics | Maintained: Buy | $23 | $17.93 | +28.28% | 51 | Jul 17, 2026 | |
| MANE Veradermics | Rated: Buy | $136 → $164 | $101.00 | +62.38% | 2 | Jul 15, 2026 | |
| AMPH Amphastar Pharmaceuticals | Maintained: Hold | n/a | $20.22 | - | 44 | Jul 8, 2026 | |
| EOLS Evolus | Maintained: Hold | n/a | $6.04 | - | 30 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $8.82 | +81.51% | 57 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $25.84 | +39.35% | 34 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $34 | $19.31 | +76.12% | 35 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $17.42 | +72.22% | 25 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.5168 | - | 61 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $7.55 | +98.81% | 35 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.12 | - | 47 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 | $35.43 | +58.08% | 167 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $70 | $83.86 | -16.53% | 71 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $78 | $62.37 | +25.06% | 39 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.32 | n/a | 9 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.75 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $2.16 | n/a | 1 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.007 | n/a | 2 | Jun 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $5 | $0.078 | n/a | 3 | Aug 19, 2016 |
Ocular Therapeutix
Aug 3, 2026
Maintained: Buy
Price Target: $18
Current: $8.38
Upside: +114.93%
Oculis Holding AG
Aug 3, 2026
Maintained: Buy
Price Target: $38
Current: $11.90
Upside: +219.33%
Cytokinetics
Jul 30, 2026
Maintained: Buy
Price Target: $102
Current: $76.42
Upside: +33.47%
Omeros
Jul 27, 2026
Maintained: Hold
Price Target: n/a
Current: $12.54
Upside: -
Pacira BioSciences
Jul 27, 2026
Maintained: Buy
Price Target: $32
Current: $26.88
Upside: +19.05%
NewAmsterdam Pharma Company
Jul 24, 2026
Maintained: Buy
Price Target: $48
Current: $27.38
Upside: +75.31%
Trevi Therapeutics
Jul 17, 2026
Maintained: Buy
Price Target: $23
Current: $17.93
Upside: +28.28%
Veradermics
Jul 15, 2026
Rated: Buy
Price Target: $136 → $164
Current: $101.00
Upside: +62.38%
Amphastar Pharmaceuticals
Jul 8, 2026
Maintained: Hold
Price Target: n/a
Current: $20.22
Upside: -
Evolus
Jul 8, 2026
Maintained: Hold
Price Target: n/a
Current: $6.04
Upside: -
Jun 30, 2026
Maintained: Buy
Price Target: $16
Current: $8.82
Upside: +81.51%
Jun 30, 2026
Maintained: Buy
Price Target: $36
Current: $25.84
Upside: +39.35%
Jun 29, 2026
Maintained: Buy
Price Target: $32 → $34
Current: $19.31
Upside: +76.12%
Jun 22, 2026
Maintained: Buy
Price Target: $30
Current: $17.42
Upside: +72.22%
Jun 2, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.5168
Upside: -
May 14, 2026
Maintained: Buy
Price Target: $15
Current: $7.55
Upside: +98.81%
May 13, 2026
Rated: Hold
Price Target: n/a
Current: $5.12
Upside: -
May 12, 2026
Maintained: Buy
Price Target: $56
Current: $35.43
Upside: +58.08%
May 11, 2026
Maintained: Buy
Price Target: $54 → $70
Current: $83.86
Upside: -16.53%
May 8, 2026
Maintained: Buy
Price Target: $80 → $78
Current: $62.37
Upside: +25.06%
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $1.32
Upside: n/a
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $0.75
Upside: n/a
Nov 5, 2021
Maintained: Buy
Price Target: $22
Current: $2.16
Upside: n/a
Jun 26, 2017
Reiterated: Hold
Price Target: n/a
Current: $0.007
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $11 → $5
Current: $0.078
Upside: n/a